These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 3327662)
1. [Comparison of human monocomponent insulin with beef and pork monocomponent insulin in the treatment of a diabetic with insulin resistance]. Wu W; Nolte M; Karam J Zhonghua Nei Ke Za Zhi; 1987 Nov; 26(11):644-5, 677. PubMed ID: 3327662 [No Abstract] [Full Text] [Related]
2. The production and characteristics of anti-insulin, anti-A-component and anti-proinsulin antibodies in patients treated with monocomponent or conventional insulin. Kawazu S; Kanazawa Y; Miki E; Hayashi M; Sando H; Kajinuma H; Iwamoto Y; Akanuma Y; Kosaka K Acta Diabetol Lat; 1979; 16(4):339-51. PubMed ID: 399151 [TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of monocomponent human and porcine insulin in non-insulin dependent diabetes mellitus. Lam HC; Tang KT; Wang JT; Liu YF; Wang LM; Ho LT Zhonghua Yi Xue Za Zhi (Taipei); 1988 Mar; 41(3):217-22. PubMed ID: 3052740 [No Abstract] [Full Text] [Related]
4. A twelve month double-blind randomized study of the efficacy and immunogenicity of human and porcine insulins in non-insulin-dependent diabetics. HO LT; Lam HC; Wu MS; Kwok CF; Jap TS; Tang KT; Wang LM; Liu YF Zhonghua Yi Xue Za Zhi (Taipei); 1991 May; 47(5):313-9. PubMed ID: 1649672 [TBL] [Abstract][Full Text] [Related]
5. [Proinsulin and a-component antibodies in diabetics treated with monocomponent and conventional insulin]. Gamba S; Barbero PL; Bollati C; Castellazzi R; D'Adda A; Bruni B Minerva Dietol Gastroenterol; 1979; 25(3):309-14. PubMed ID: 400003 [No Abstract] [Full Text] [Related]
6. Immunogenicity of human insulin (Novo) or pork monocomponent insulin in HLA-DR-typed insulin-dependent diabetic individuals. Schernthaner G; Borkenstein M; Fink M; Mayr WR; Menzel J; Schober E Diabetes Care; 1983; 6 Suppl 1():43-8. PubMed ID: 6343038 [TBL] [Abstract][Full Text] [Related]
7. [Insulin antibodies and immune complexes in long-term diabetics switched to monocomponent human insulin]. Iavicoli M; Di Mario U; Coronel GA; Musacchio N; Arduini P Minerva Endocrinol; 1984; 9(2):115-20. PubMed ID: 6390124 [No Abstract] [Full Text] [Related]
8. Comparison of purified bovine and monocomponent porcine insulins. Johnson Z; McDonnell J; Devlin JG Ir Med J; 1984 Dec; 77(12):380-1, 383. PubMed ID: 6394540 [No Abstract] [Full Text] [Related]
9. [Purity and antigenicity of the new insulin preparations]. Fankhauser S Schweiz Med Wochenschr; 1976 Sep; 106(36):1218-25. PubMed ID: 996531 [TBL] [Abstract][Full Text] [Related]
10. Successful treatment of immune-mediated insulin resistance by human insulin (recombinant DNA). Maneschi F; Fineberg SE; Kohner EM Diabetes Care; 1982; 5 Suppl 2():175-9. PubMed ID: 6765532 [TBL] [Abstract][Full Text] [Related]
11. Comparison of insulin antibody levels during the first 3 years of treatment of adult diabetics with monocomponent porcine lente-insulin and single peak beef NPH insulin. Wajchenberg BL; Thomsen YG; Toledo e Souza IT; Germek OA Horm Metab Res; 1986 Aug; 18(8):535-9. PubMed ID: 3758926 [TBL] [Abstract][Full Text] [Related]
12. Reduction in insulin antibodies 42 months after transfer from porcine to human monocomponent insulins. Virgili F; Frigato F; Magnanini PG; Coronel GA; Iavicoli M Diabetes Res; 1988 Sep; 9(1):19-20. PubMed ID: 3071441 [TBL] [Abstract][Full Text] [Related]
13. Receptor binding studies and clinical effects of human insulin (recombinant DNA): studies in patients with newly diagnosed type i diabetes, type II diabetes, insulin resistance (type A and type B), insulin antibodies, insulin allergy, and "brittle" diabetes. Schlüter KJ; Kerp L Diabetes Care; 1982; 5 Suppl 2():152-60. PubMed ID: 6765528 [TBL] [Abstract][Full Text] [Related]
14. Allergy to monocomponent porcine and human insulin. Mohan V; Shyamsundar R; Ramachandran A; Viswanathan M; Snehalatha C J Assoc Physicians India; 1983 Nov; 31(11):721-2. PubMed ID: 6368524 [No Abstract] [Full Text] [Related]
15. [The place of "monocomponent" insulins in diabetes mellitus therapy]. Teuscher A Schweiz Med Wochenschr; 1975 Apr; 105(16):485-94. PubMed ID: 1215860 [TBL] [Abstract][Full Text] [Related]
16. Comparative trials with monocomponent (MC) and monospecies (MS) pork insulins in the treatment of diabetes mellitus. Influence on antibody levels, on insulin requirement and on some complications. Andreani D; Iavicoli M; Tamburrano G; Menzinger G; Maltarello C Horm Metab Res; 1974 Nov; 6(6):447-54. PubMed ID: 4476720 [No Abstract] [Full Text] [Related]
17. Serum levels of insulin-binding antibodies in diabetic patients treated with monocomponent insulin. Czyzyk A; Lawecki J; Rogala H; Miedzińska E; Popik-Hankiewicz A Diabetologia; 1974 Jun; 10(3):233-6. PubMed ID: 4845724 [No Abstract] [Full Text] [Related]
18. [Avidity and binding capacity of bovine and porcine insulin binding antibodies in childhood diabetes]. Hürter P; Kühnau J Monatsschr Kinderheilkd (1902); 1970 Jun; 118(6):250-2. PubMed ID: 5535600 [No Abstract] [Full Text] [Related]
19. [Serum levels of insulin-binding antibodies in diabetic children treated with monocomponent insulin]. Symonides-Lawecka A; Ludwiczak H; Rogala H; Lawecki J; Czyzyk A Pol Tyg Lek; 1974 Apr; 29(16):641-3. PubMed ID: 4827230 [No Abstract] [Full Text] [Related]
20. [Insulin antibodies and the actual insulin requirements in children and adolescents with primary diabetes]. Karczewska K; Feluś E; Panek G; Otto-Buczkowska E; Dudziak Z Med Dosw Mikrobiol; 1974; 26(4):325-30. PubMed ID: 4475336 [No Abstract] [Full Text] [Related] [Next] [New Search]